REPUBLIC HC(08357) issued a profit warning, expecting a net loss of approximately 3.7 million Singapore dollars in the fiscal year 2025 compared to the previous year.
HC(08357) announced that the Group expects its net loss for the fiscal year ending December 31, 2025 (during the period) to increase significantly by approximately 3.7 million Singapore dollars compared to the same period in 2024.
HC (08357) issued an announcement, expecting its net loss for the year ending December 31, 2025 (the period) to increase significantly by approximately 3.7 million Singapore dollars compared to the same period in 2024.
The increase in net loss attributable to shareholders is mainly due to the following factors: 1. Decrease in revenue due to intensified market competition, resulting in lower revenue for the group. The entry of new participants and the active expansion of existing competitors have significantly increased competitive pressure. Many participants have intensified their marketing efforts and launched new service projects, diverting some of the group's existing patient groups. 2. Macroeconomic pressures, changes in tariffs, and uncertainty in the economic environment have made patients more sensitive to prices, further affecting the group's revenue. 3. Regulatory developments: recent revisions to healthcare regulations have increased the group's compliance and operational burdens, resulting in a decline in overall financial performance. 4. Increase in operating expenses: (a) The group incurred exchange losses due to the significant depreciation of the US dollar and Hong Kong dollar against the Singapore dollar (the group's functional currency). (b) The group's education business in the Philippines and the expansion of medical business in the Chinese market incurred higher operating costs. These initiatives were not implemented in the previous year, and are currently in the early stages of investment and development. Therefore, they have not yet generated significant revenue contributions, and the related prior period costs have also contributed to the group's loss during the period.
Related Articles

EB SECURITIES: Shanghai Electric Group (02727) continues to make breakthroughs in emerging industries such as 25 years of nuclear fusion and Siasun Robot & Automation. We maintain a "buy" rating.

Guosheng Macro: Jobs in the United States show signs of improvement in March, but underlying worries remain.

Industrial: Market fluctuations intensify. How are various types of funds moving?
EB SECURITIES: Shanghai Electric Group (02727) continues to make breakthroughs in emerging industries such as 25 years of nuclear fusion and Siasun Robot & Automation. We maintain a "buy" rating.

Guosheng Macro: Jobs in the United States show signs of improvement in March, but underlying worries remain.

Industrial: Market fluctuations intensify. How are various types of funds moving?

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


